参考文献/References:
[1] BUSKWOFIE A, DAVID-WEST G, CLARE C A. A review of cervical cancer: incidence and disparities[J]. Journal of the National Medical Association, 2020, 112(2): 229-232.
[2] NITECKI R, RAMIREZ P T, FRUMOVITZ M,et al. Survival after minimally invasive vs open radical hysterectomy for early-stage cervical cancer: a systematic review and meta-analysis[J]. JAMA Oncology, 2020, 6(7): 1019-1027.
[3] KILITI A J, SHARIF G M, MARTIN M B, et al. AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer[J]. Frontiers in Endocrinology, 2023, 14: 1250218.
[4] KILITI A J, SHARIF G M, WELLSTEIN A, et al. Subpopulations of AIB1 isoform-expressing breast cancer cells enable invasion and metastasis [J]. Oncotarget, 2023, 14: 780-781.
[5] CHEN Min, YANG Xue, LIU Haiyang, et al. Identification and functional characterization of a bipartite nuclear localization signal in ANKRD11[J]. Biochemical and Biophysical Research Communications, 2023, 670: 117-123.
[6] ZHANG Can, MOBERG K. One repressor to rule them all: ANCO1 links YAP and AIB1[J]. EMBO Reports,2020, 21(1): e49647.
[7] 杨学丽, 安欣, 姜琳娜, 等. 宫颈癌组织FBN1 基因甲基化状态与临床病理特征及预后的相关性研究[J]. 现代检验医学杂志, 2023, 38(1): 11-15. YANG Xueli, AN Xin, JIANG Linna, et al. Correlation between methylation status of FBN1 gene in cervical cancer tissue and clinicopathological features and prognosis[J]. Journal of Modern Laboratory Medicine, 2023, 38(1): 11-15.
[8] KECHAGIAS K S, KALLIALA I, BOWDEN S J, et al.Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis[J]. BMJ (Clinical Research Ed.), 2022, 378: e070135.
[9] LI Jianwei, QU Hua, WANG Yong. AIB1 deficiency exacerbates inflammatory responses in acute myocardial infarction mice[J]. Journal of Molecular Medicine, 2022, 100(8): 1181-1190.
[10] OH J H, LEE J Y, KIM K H, et al. Elevated GCN5 expression confers tamoxifen resistance by upregulating AIB1 expression in ER-positive breast cancer[J]. Cancer Letters, 2020, 495: 145-155.
[11] MILLER J, DAKIC A, SPURGEON M, et al. AIB1 is a novel target of the high-risk HPV E6 protein and a biomarker of cervical cancer progression[J]. Journal of Medical Virology, 2022, 94(8): 3962-3977.
[12] LI Licen, DENG Chuxia, CHEN Qiang. SRC-3, a steroid receptor coactivator: implication in cancer[J]. International Journal of Molecular Sciences, 2021, 22(9): 4760.
[13] VARE?LIJA D, WARD E, PURCELL S P, et al. Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-cadherin to promote EMT and associates with a prometastatic phenotype[J]. Oncogene, 2021, 40(7): 1318-1331.
[14] ZHAO Zhenfeng, ZHOU Shuguang, LI Wenyu, et al. AIB1 predicts tumor response to definitive chemoradiotherapy and prognosis in cervical squamous cell carcinoma[J]. Journal of Cancer, 2019, 10(21): 5212-5222.
[15] SOROKIN D Y, DIENDER M, MERKEL A Y, et al. Natranaerofaba carboxydovora gen. nov., sp. nov.,an extremely haloalkaliphilic CO-utilizing acetogen from a hypersaline soda lake representing a novel deep phylogenetic lineage in the class ‘Natranaerobiia’[J]. Environmental Microbiology, 2021, 23(7): 3460-3476.
[16] 朱德明, 孔连宝, 贾文博, 等. ANKRD1 通过介导上皮细胞间充质转化促进肝细胞肝癌增殖与转移[J]. 南京医科大学学报(自然科学版), 2023, 43(4): 484-491. ZHU Deming, KONG Lianbao, JIA Wenbo, et al. ANKRD1 promotes proliferation and metastasis of hepatocellular carcinoma by activating epithelial mesenchymal transition pathway[J]. Journal of Nanjing Medical University (Natural Sciences), 2023, 43(4): 484-491.
[17] YUAN Meng, BAREFOOT M E, PETERSON K, et al. Loss of ANCO1 expression regulates chromatin accessibility and drives progression of early-stage triple-negative breast cancer[J]. International Journal of Molecular Sciences, 2023, 24(14): 11505.
[18] DAVIS O. Abnormal chromatin folding in the molecular pathogenesis of epilepsy and autism spectrum disorder: a meta-synthesis with systematic searching[J]. Molecular Neurobiology, 2023, 60(2): 768-779.
[19] KUSHNER M H, ORY V, GRAHAM G T, et al. Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression[J]. EMBO Reports, 2020, 21(1): e48741.
相似文献/References:
[1]田英,王双勇,赵雅,等.宫颈癌组织细胞中Numb基因表达及相关性研究[J].现代检验医学杂志,2015,30(06):42.[doi:10.3969/j.issn.1671-7414.2015.06.012]
TIAN Ying,WANG Shuang-yong,ZHAO Ya,et al.Study on Correlation and Expression of Numb Gene in Cervical Cancer[J].Journal of Modern Laboratory Medicine,2015,30(06):42.[doi:10.3969/j.issn.1671-7414.2015.06.012]
[2]刘小君,向华国,曾锦婷,等.荧光探针PCR与膜芯片技术在女性生殖道HPV分型的对比研究[J].现代检验医学杂志,2015,30(06):92.[doi:10.3969/j.issn.1671-7414.2015.06.027]
LIU Xiao-jun,XIANG Hua-guo,ZENG Jin-ting,et al.Study on Comparing with the Fluorescence
Probe PCR and Film Chip Technology for Genotyping Human
Papilloma Virus in the Female Reproductive Tract[J].Journal of Modern Laboratory Medicine,2015,30(06):92.[doi:10.3969/j.issn.1671-7414.2015.06.027]
[3]顾益凤,朱自力,史跃燕,等.血浆硫氧还蛋白还原酶水平检测对宫颈癌早期诊断的价值研究[J].现代检验医学杂志,2019,34(02):40.[doi:10.3969/j.issn.1671-7414.2019.02.011]
GU Yi-feng,ZHU Zi-li,SHI Yue-yan,et al.Study on the Value of Plasma Thioredoxin Reductase Levelin the Early Diagnosis of Cervical Cancer[J].Journal of Modern Laboratory Medicine,2019,34(06):40.[doi:10.3969/j.issn.1671-7414.2019.02.011]
[4]陈 慎,杜明君,宋雅琴.宫颈组织HPV DNA与血清Chemerin,Leptin水平联合检测对宫颈癌早期诊断的价值分析[J].现代检验医学杂志,2019,34(03):42.[doi:10.3969/j.issn.1671-7414.2019.03.010]
CHEN Shen,DU Ming-jun,SONG Ya-qin.Value of Combined Detection of HPV DNA and Serum Levelsof Chemerin and Leptin in Early Diagnosis of Cervical Cancer[J].Journal of Modern Laboratory Medicine,2019,34(06):42.[doi:10.3969/j.issn.1671-7414.2019.03.010]
[5]周 静,李 智,周 玉,等.宫颈癌组织中 Ep-CAM和 Ki67的表达及临床意义[J].现代检验医学杂志,2019,34(06):24.[doi:10.3969 ／ j.issn.1671-7414.2019.06.006]
ZHOU Jing,LI Zhi,ZHOU Yu,et al.Expression and Clinicd Value of Ep-CAM and Ki67 in the Cervial Carcinoma Tissue[J].Journal of Modern Laboratory Medicine,2019,34(06):24.[doi:10.3969 ／ j.issn.1671-7414.2019.06.006]
[6]徐晓锋a,王 纯b,卢国丰a,等.宫颈癌患者 Kruppel 样因子 6，p21 蛋白表达水平与病理特征及化疗敏感性的相关性分析[J].现代检验医学杂志,2020,35(06):12.[doi:doi:10.3969/j.issn.1671-7414.2020.06.004]
XU Xiao-feng a,WANG Chun b,LU Guo-feng a,et al.Correlation Analysis of KLF6 and p21 Protein Expression Levels andPathological Features and Chemotherapy Sensitivity in Patientswith Cervical Cancer[J].Journal of Modern Laboratory Medicine,2020,35(06):12.[doi:doi:10.3969/j.issn.1671-7414.2020.06.004]
[7]高红敏,杨红英,刘 鑫.血清中 microRNA-106b 对宫颈癌患者的早期诊断及预后预测价值[J].现代检验医学杂志,2020,35(06):85.[doi:doi:10.3969/j.issn.1671-7414.2020.06.020]
GAO Hong-min,YANG Hong-ying,LIU Xin.Value Analysis of Serum microRNA-106b in Early Diagnosis ofCervical Cancer[J].Journal of Modern Laboratory Medicine,2020,35(06):85.[doi:doi:10.3969/j.issn.1671-7414.2020.06.020]
[8]赵白信,于慧娟,焦方杰,等.经阴道彩色多普勒超声联合血清 miR-130a，miR-425-5p 水平检测对宫颈癌的诊断效能分析[J].现代检验医学杂志,2021,36(03):43.[doi:10.3969/j.issn.1671-7414.2021.03.010]
ZHAO Bai-xin,YU Hui-juan,JIAO Fang-jie,et al.Analysis of Diagnostic Efficacy of Transvaginal Color Doppler UltrasoundCombined with Serum miR-130a and miR-425-5p Levels in Cervical Cancer[J].Journal of Modern Laboratory Medicine,2021,36(06):43.[doi:10.3969/j.issn.1671-7414.2021.03.010]
[9]张治洋,李功娟.10株宫颈癌细胞系中MALAT1的表达及其对顺铂敏感性的影响[J].现代检验医学杂志,2021,36(05):110.[doi:10.3969/j.issn.1671-7414.2021.05.024]
ZHANG Zhi-yang,LI Gong-juan.Expression of MALAT1 in 10 Cervical Cancer Cell Lines and Its Effect onCisplatin Sensitivity[J].Journal of Modern Laboratory Medicine,2021,36(06):110.[doi:10.3969/j.issn.1671-7414.2021.05.024]
[10]郝艳芳,刘亚荣,黄玲玲,等.miRNA-195靶向调控 CCND2和 MYB抑制宫颈癌细胞增殖、迁移的机制研究[J].现代检验医学杂志,2022,37(01):130.[doi:10.3969/j.issn.1671-7414.2022.01.026]
HAO Yan-fang,LIU Ya-rong,HUANG Ling-ling,et al.Study on the Mechanism of miRNA-195 Targeting CCND2 and MYB to Inhibit the Proliferation and Migration of Cervical Cancer Cells[J].Journal of Modern Laboratory Medicine,2022,37(06):130.[doi:10.3969/j.issn.1671-7414.2022.01.026]